Candidiasis (Vulvovaginal)

NICE CKS Candida - female genital. Last revised: Oct 2023. BASHH Vulvovaginal Candidiasis 2019. Last updated: Jan 2021.

Background Information

Vulvovaginal candidiasis (genital thrush): symptomatic inflammation of vagina and/or vulva secondary to fungal infection.

Recurrent infection: ≥4 symptomatic episodes in 1 year, at least 2 confirmed by microscopy / culture (at least one by culture)

Most common genus: Candida yeasts
  • Most common species: Candida albicans (80-89% cases)
  • Candida glabrata (5%)

  • Local irritants - douching, soaps, shampoos, shower gels
  • Recent antibiotic use (within 3 months)
  • Immunosupression
    • Poorly controlled diabetes mellitus
    • HIV infection
    • Long-term corticosteroid use
  • Oestrogen exposure
    • Pregnancy
    • COCP Combined oral contraceptive pill
    • HRTHormone replacement therapy  

Possible symptoms:
  • Vulval / vaginal itching (most common), soreness and irritation
  • Superficial dyspareunia and dysuria

On examination:
  • White 'cheese-like' discharge (non-malodorus)
  • Erythema
  • Vaginal fissuring and/or oedema
  • Excoriations
  • Satellite lesions (rare - may indicate other fungal conditions or HSV infection)

Guidelines

Clinical diagnosis is usually sufficient in the presence of typical signs and symtpoms.


Consider the following for recurrent infection / diagnostic uncertainty:
  • High vaginal swab of vaginal secretions for microscopy 
    • Self-collected low vulvovaginal swab is also appropriate (if examination of external genitalia not possible or not needed)
    • Culture might be needed for recurrent infection
  • Vaginal pH testing of secretions 
    • pH <4.5 supports candidiasis
    • Not needed for diagnosis, but helpful to exclude bacterial vaginosis and trichomoniasis
  • Midstream sample of urine 
    • If UTI is suspected
 
  • HbA1c - to exclude diabetes mellitus 
  • FBC and serum ferritin - to exclude iron deficiency anaemia

Choice of anti-fungal:
  • 1st line: oral fluconazole 150mg single dose
  • 2nd line: topical clotrimazole 500mg intravaginal pessary single dose 

If there are vulval symptoms: consider adding topical clotrimazole 1% / 2% cream 2-3 times a day
 

Definition: if no response to initial treatment within 7-14 days
  • Perform high vaginal swab 
  • Treat according to high vaginal swab results
 

Offer an induction-maintenance regimen:
  • Induction: 3 doses of oral fluconazole 150mg - to be taken every 72 hours
  • Maintenance: oral fluconazole 150mg once a week for 6 months

2nd line induction-maintenance regimen:
  • Induction: topical clotrimazole 500mg intravaginal pessary up to 7-14 days
  • Maintenance: topical clotrimazole 500mg intravaginal pessary once a week for 6 months OR oral itraconazole 50-100mg daily for 6 months

Choice of anti-fungal:
  • 1st line: topical clotrimazole intravaginal pessary at night for up to 7 consecutive nights

If there are vulval symptoms: consider adding topical clotrimazole 1% / 2% cream 2-3 times a day

 

Oral fluconazole and itraconazole are both contraindicated in pregnancy.

Topical antifungals ​​​​​​are safe alternatives in pregnancy.

Author: Adams Lau
Reviewer:
Last edited: 30/06/25